Analyst Recommendations

Craig-Hallum analyst issues BUY recommendation for VUZI on October 1, 2025 03:59PM ET. The previous analyst recommendation was Buy.VUZI was trading at $3.48 at issue of the analyst...

October 1, 2025   VUZI -0.38%

Jefferies analyst issues BUY recommendation for ENTA on October 1, 2025 02:21PM ET. ENTA was trading at $10.8849 at issue of the analyst recommendation.The overall analyst consensus :...

October 1, 2025   ENTA -0.36%

Benchmark analyst issues BUY recommendation for DAVE on October 1, 2025 01:03PM ET. The previous analyst recommendation was Buy.DAVE was trading at $208.07 at issue of the analyst...

October 1, 2025   DAVE 7.62%

Roth Capital analyst issues BUY recommendation for IPX on October 1, 2025 11:45AM ET. The previous analyst recommendation was Buy.IPX was trading at $49.35 at issue of the...

October 1, 2025   IPX -1.59%

Citigroup analyst issues OUTPERFORM recommendation for OCUL on October 1, 2025 09:57AM ET. The previous analyst recommendation was Outperform.OCUL was trading at $11.69 at issue of the analyst...

October 1, 2025   OCUL 10.84%

Needham analyst issues BUY recommendation for LTRX on September 30, 2025 01:01PM ET. The previous analyst recommendation was Buy.LTRX was trading at $4.585 at issue of the analyst...

September 30, 2025   LTRX 0.00%

B. Riley analyst issues NEUTRAL recommendation for EOSE on September 30, 2025 12:27PM ET. The previous analyst recommendation was Neutral.EOSE was trading at $11.17 at issue of the...

September 30, 2025   EOSE 0.70%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for ESPR on September 25, 2025 06:15PM ET. The previous analyst recommendation was Overweight.ESPR was trading at $2.56 at issue of the...

September 26, 2025   ESPR -0.49%

Cowen & Co. analyst issues BUY recommendation for MVBF on September 24, 2025 08:24PM ET. MVBF was trading at $24.2 at issue of the analyst recommendation.The overall analyst...

September 25, 2025   MVBF 3.28%

Oppenheimer analyst issues OUTPERFORM recommendation for IMRX on September 25, 2025 12:57PM ET. The previous analyst recommendation was Outperform.IMRX was trading at $9.23 at issue of the analyst...

September 25, 2025   IMRX -0.18%